{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:24:46Z","timestamp":1794014686484,"version":"4.8.0"},"reference-count":31,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"\n OBJECTIVE<\/jats:title>\n The authors aimed to determine whether differences exist in presentation and natural history when comparing Asian patients with moyamoya disease (MMD) to those of other ethnicities in North America.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n A database of 137 patients with MMD presenting to their institution between 1994 and 2015 was reviewed. Baseline characteristics and outcome variables, including stroke and functional outcome, were compared between Asian and non-Asian patients. Unadjusted Kaplan-Meier survival analysis and adjusted Cox regression models were used to compare stroke-free survival and stroke hazard after diagnosis among hemispheres of both racial groups. The analysis was stratified by age group, and censoring was performed until last follow-up or at the time of surgery. Because the relative rate of stroke changed between Asian and non-Asian adults after 1.5 years of follow-up, a time-segmented analysis focusing on the period 1.5 years after diagnosis was performed.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n \n The cohort comprised 23% (31\/137) Asian and 77% (106\/137) non-Asian patients with MMD with a bimodal age distribution. Non-Asian patients had a higher prevalence of increased BMI (p = 0.02) and smoking (p = 0.04). Among patients who presented with stroke (n = 90), hemorrhage was significantly more common among Asians (p = 0.02). The natural history analysis included 250 hemispheres: 67 pediatric and 183 adult hemispheres. The overall mean follow-up duration since diagnosis was 3.3 years. Among adults, Asian patients had a higher incidence of stroke (8.0 per 100 person-years vs 3.0 per 100 person-years) over a mean follow-up of 3.3 years, but results were not statistically significant (p\n =<\/jats:italic>\n 0.45). In the period beginning 1.5 years after diagnosis, Asian adults had a significantly higher hazard of stroke over a mean follow-up of 7.7 years, while controlling for sex, hypertension, and stroke before diagnosis (hazard ratio 8.8, p\n =<\/jats:italic>\n 0.02). Among pediatric patients, Asians also had a higher stroke incidence (10.0 per 100 person-years vs 3.5 per 100 person-years) over a mean follow-up of 3.2 years; however, results did not reach statistical significance (p = 0.40). Functional outcome was similar between both ethnic groups at last follow-up (p = 0.57).\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n This study suggests a comparatively more progressive course of MMD in Asians. Further studies are required to fully characterize the phenotypic distinctions between different races and underlying pathophysiological mechanisms.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2019.7.jns191507","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T20:11:58Z","timestamp":1570824718000},"page":"1766-1772","source":"Crossref","is-referenced-by-count":11,"title":["Racial phenotypes in moyamoya disease: a comparative analysis of clinical presentation and natural history in a single multiethnic cohort of 250 hemispheres"],"prefix":"10.3171","volume":"133","author":[{"given":"James","family":"Feghali","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyang","family":"Yang","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Liew","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael J.","family":"Tamargo","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth B.","family":"Marsh","sequence":"additional","affiliation":[{"name":"Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Huang","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/STROKEAHA.111.000307","article-title":"Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease","volume":"44","author":"Bower RS","year":"2013","unstructured":"Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB: Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease. Stroke 44:1997\u20131999, 201310.1161\/STROKEAHA.111.000307"},{"key":"b2","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3171\/2017.12.JNS172178","article-title":"Risk of subsequent stroke, with or without extracranial-intracranial bypass surgery: a nationwide, retrospective, population-based study","volume":"130","author":"Chen X","year":"2019","unstructured":"Chen X, Lin CL, Su YC, Chen KF, Lai SW, Wei ST, : Risk of subsequent stroke, with or without extracranial-intracranial bypass surgery: a nationwide, retrospective, population-based study. J Neurosurg 130:1906\u20131913, 201910.3171\/2017.12.JNS172178"},{"key":"b3","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/01.STR.29.7.1347","article-title":"Clinical features of moyamoya disease in the United States","volume":"29","author":"Chiu D","year":"1998","unstructured":"Chiu D, Shedden P, Bratina P, Grotta JC: Clinical features of moyamoya disease in the United States. Stroke 29:1347\u20131351, 1998966038510.1161\/01.STR.29.7.1347"},{"key":"b4","series-title":"Neuroradiology","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s002340050840","article-title":"Idiopathic supraclinoid and internal carotid bifurcation steno-occlusive disease in young American adults","volume":"41","author":"Cloft HJ","year":"1999","unstructured":"Cloft HJ, Kallmes DF, Snider R, Jensen ME: Idiopathic supraclinoid and internal carotid bifurcation steno-occlusive disease in young American adults. Neuroradiology 41:772\u2013776, 199910.1007\/s00234005084010552029"},{"key":"b5","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2176\/nmc.32.883","article-title":"Worldwide distribution of moyamoya disease","volume":"32","author":"Goto Y","year":"1992","unstructured":"Goto Y, Yonekawa Y: Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 32:883\u2013886, 199210.2176\/nmc.32.8831282678"},{"key":"b6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3171\/2009.4.JNS081649","article-title":"Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article","volume":"111","author":"Guzman R","year":"2009","unstructured":"Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, : Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111:927\u2013935, 20091946304610.3171\/2009.4.JNS081649"},{"key":"b7","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1161\/01.STR.0000221787.70503.ca","article-title":"Clinical features and outcome in North American adults with moyamoya phenomenon","volume":"37","author":"Hallemeier CL","year":"2006","unstructured":"Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT III, : Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37:1490\u20131496, 20061664513310.1161\/01.STR.0000221787.70503.ca"},{"key":"b8","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/neuros\/nyy236","article-title":"Impact of interethnic difference of collateral angioarchitectures on prevalence of hemorrhagic stroke in moyamoya disease","volume":"85","author":"Hori S","year":"2019","unstructured":"Hori S, Kashiwazaki D, Yamamoto S, Acker G, Czabanka M, Akioka N, : Impact of interethnic difference of collateral angioarchitectures on prevalence of hemorrhagic stroke in moyamoya disease. Neurosurgery 85:134\u2013146, 20192988927310.1093\/neuros\/nyy236"},{"key":"b9","series-title":"Neuroepidemiology","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000345957","article-title":"Epidemiological and clinical features of moyamoya disease in the USA","volume":"40","author":"Kainth D","year":"2013","unstructured":"Kainth D, Chaudhry SA, Kainth H, Suri FK, Qureshi AI: Epidemiological and clinical features of moyamoya disease in the USA. Neuroepidemiology 40:282\u2013287, 201310.1159\/00034595723445954"},{"key":"b10","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1161\/STROKEAHA.107.513408","article-title":"Moyamoya disease in Europeans","volume":"39","author":"Kraemer M","year":"2008","unstructured":"Kraemer M, Heienbrok W, Berlit P: Moyamoya disease in Europeans. Stroke 39:3193\u20133200, 200810.1161\/STROKEAHA.107.51340818787200"},{"key":"b11","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/STROKEAHA.107.490714","article-title":"Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey","volume":"39","author":"Kuriyama S","year":"2008","unstructured":"Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, : Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42\u201347, 200810.1161\/STROKEAHA.107.49071418048855"},{"key":"b12","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda S","year":"2008","unstructured":"Kuroda S, Houkin K: Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056\u20131066, 200810.1016\/S1474-4422(08)70240-018940695"},{"key":"b13","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1212\/WNL.41.12.1893","article-title":"Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use","volume":"41","author":"Levine SR","year":"1991","unstructured":"Levine SR, Fagan SC, Pessin MS, Silbergleit R, Floberg J, Selwa JF, : Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use. Neurology 41:1893\u20131901, 199110.1212\/WNL.41.12.18931745344"},{"key":"b14","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3171\/2014.10.JNS132369","article-title":"Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China","volume":"122","author":"Liu XJ","year":"2015","unstructured":"Liu XJ, Zhang D, Wang S, Zhao YL, Teo M, Wang R, : Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. J Neurosurg 122:392\u2013399, 201510.3171\/2014.10.JNS13236925423267"},{"key":"b15","series-title":"J Am Heart Assoc","doi-asserted-by":"publisher","first-page":"e007462","DOI":"10.1161\/JAHA.117.007462","article-title":"Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States","volume":"7","author":"Lu Y","year":"2018","unstructured":"Lu Y, Wang P, Zhou T, Lu J, Spatz ES, Nasir K, : Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States. J Am Heart Assoc 7:e007462, 201810.1161\/JAHA.117.00746229374046"},{"key":"b16","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1227\/NEU.0000000000000162","article-title":"Surgical outcomes and predictors of stroke in a North American white and African American moyamoya population","volume":"73","author":"Mallory GW","year":"2013","unstructured":"Mallory GW, Bower RS, Nwojo ME, Taussky P, Wetjen NM, Varzoni TC, : Surgical outcomes and predictors of stroke in a North American white and African American moyamoya population. Neurosurgery 73:984\u2013991, 981\u2013982, 201310.1227\/NEU.0000000000000162"},{"key":"b17","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1212\/01.wnl.0000314695.96436.19","article-title":"Heterogeneity of Moyamoya disease. After a decade of linkage, is there new hope for a gene?","volume":"70","author":"Meschia JF","year":"2008","unstructured":"Meschia JF, Ross OA: Heterogeneity of Moyamoya disease. After a decade of linkage, is there new hope for a gene? Neurology 70:2353\u20132354, 20081854186810.1212\/01.wnl.0000314695.96436.19"},{"issue":"Suppl 2","key":"b18","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/S0303-8467(97)00060-7","article-title":"Moyamoya disease in the United States","volume":"99","author":"Numaguchi Y","year":"1997","unstructured":"Numaguchi Y, Gonzalez CF, Davis PC, Monajati A, Afshani E, Chang J, : Moyamoya disease in the United States. Clin Neurol Neurosurg 99 (Suppl 2):S26\u2013S30, 199710.1016\/S0303-8467(97)00060-79409400"},{"key":"b19","series-title":"Childs Nerv Syst","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00381-012-1708-x","article-title":"Discovery of cerebrovascular moyamoya disease: research during the late 1950s and early 1960s","volume":"28","author":"Oshima H","year":"2012","unstructured":"Oshima H, Katayama Y: Discovery of cerebrovascular moyamoya disease: research during the late 1950s and early 1960s. Childs Nerv Syst 28:497\u2013500, 201210.1007\/s00381-012-1708-x22327249"},{"issue":"Suppl 2","key":"b20","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/S0303-8467(97)00039-5","article-title":"Risk factors of moyamoya disease in Canada and the USA","volume":"99","author":"Peerless SJ","year":"1997","unstructured":"Peerless SJ: Risk factors of moyamoya disease in Canada and the USA. Clin Neurol Neurosurg 99 (Suppl 2):S45\u2013S48, 1997940940410.1016\/S0303-8467(97)00039-5"},{"key":"b21","series-title":"Neurol Med Chir (Tokyo)","first-page":"245","article-title":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle Willis: Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle Willis: Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52:245\u2013266, 201222870528"},{"key":"b22","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott RM","year":"2009","unstructured":"Scott RM, Smith ER: Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226\u20131237, 200910.1056\/NEJMra080462219297575"},{"key":"b23","series-title":"G3 (Bethesda)","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1534\/g3.115.020321","article-title":"Disease variant landscape of a large multiethnic population of moyamoya patients by exome sequencing","volume":"6","author":"Shoemaker LD","year":"2015","unstructured":"Shoemaker LD, Clark MJ, Patwardhan A, Chandratillake G, Garcia S, Chen R, : Disease variant landscape of a large multiethnic population of moyamoya patients by exome sequencing. G3 (Bethesda) 6:41\u201349, 201510.1534\/g3.115.02032126530418"},{"key":"b24","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1227\/NEU.0b013e318253ab8e","article-title":"Moyamoya disorder in the United States","volume":"71","author":"Starke RM","year":"2012","unstructured":"Starke RM, Crowley RW, Maltenfort M, Jabbour PM, Gonzalez LF, Tjoumakaris SI, : Moyamoya disorder in the United States. Neurosurgery 71:93\u201399, 201210.1227\/NEU.0b013e318253ab8e22418580"},{"key":"b25","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3171\/2009.3.JNS08837","article-title":"Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article","volume":"111","author":"Starke RM","year":"2009","unstructured":"Starke RM, Komotar RJ, Hickman ZL, Paz YE, Pugliese AG, Otten ML, : Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. J Neurosurg 111:936\u2013942, 200910.3171\/2009.3.JNS0883719374496"},{"key":"b26","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3174\/ajnr.A3883","article-title":"Cerebrovascular collaterals correlate with disease severity in adult North American patients with moyamoya disease","volume":"35","author":"Strother MK","year":"2014","unstructured":"Strother MK, Anderson MD, Singer RJ, Du L, Moore RD, Shyr Y, : Cerebrovascular collaterals correlate with disease severity in adult North American patients with moyamoya disease. AJNR Am J Neuroradiol 35:1318\u20131324, 20142465181410.3174\/ajnr.A3883"},{"key":"b27","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/01.STR.14.1.104","article-title":"Moyamoya disease\u2014a review","volume":"14","author":"Suzuki J","year":"1983","unstructured":"Suzuki J, Kodama N: Moyamoya disease\u2014a review. Stroke 14:104\u2013109, 1983682367810.1161\/01.STR.14.1.104"},{"key":"b28","series-title":"Brain Nerve","first-page":"37","article-title":"Hypoplasia of the bilateral internal carotid arteries","volume":"9","author":"Takeuchi K","year":"1957","unstructured":"Takeuchi K, Shimizu K: Hypoplasia of the bilateral internal carotid arteries. Brain Nerve 9:37\u201343, 1957"},{"key":"b29","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1212\/01.wnl.0000176066.33797.82","article-title":"Moyamoya disease in Washington State and California","volume":"65","author":"Uchino K","year":"2005","unstructured":"Uchino K, Johnston SC, Becker KJ, Tirschwell DL: Moyamoya disease in Washington State and California. Neurology 65:956\u2013958, 200510.1212\/01.wnl.0000176066.33797.8216186547"},{"issue":"Suppl 2","key":"b30","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0303-8467(97)00031-0","article-title":"Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey","volume":"99","author":"Wakai K","year":"1997","unstructured":"Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, : Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 99 (Suppl 2):S1\u2013S5, 199710.1016\/S0303-8467(97)00031-09409395"},{"key":"b31","series-title":"Arch Neurol","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1001\/archneur.58.8.1274","article-title":"Moyamoya: Indiana University Medical Center experience","volume":"58","author":"Yilmaz EY","year":"2001","unstructured":"Yilmaz EY, Pritz MB, Bruno A, Lopez-Yunez A, Biller J: Moyamoya: Indiana University Medical Center experience. Arch Neurol 58:1274\u20131278, 200110.1001\/archneur.58.8.127411493168"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/133\/6\/article-p1766.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/133\/6\/article-p1766.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/133\/6\/article-p1766.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:51:20Z","timestamp":1794012680000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/133\/6\/article-p1766.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2019.7.jns191507","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}